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Abstract
Objectives:  There is a growing interest in the role that light plays on nocturnal melatonin
production and, perhaps thereby, the incidence of breast cancer in modern societies. The direct
causal relationships in this logical chain have not, however, been fully established and the weakest
link is an inability to quantitatively specify architectural lighting as a stimulus for the circadian
system. The purpose of the present paper is to draw attention to this weakness.
Data Sources and Extraction: We reviewed the literature on the relationship between
melatonin, light at night, and cancer risk in humans and tumor growth in animals. More specifically,
we focused on the impact of light on nocturnal melatonin suppression in humans and on the
applicability of these data to women in real-life situations. Photometric measurement data from the
lighted environment of women at work and at home is also reported.
Data Synthesis: The literature review and measurement data demonstrate that more
quantitative knowledge is needed about circadian light exposures actually experienced by women
and girls in modern societies.
Conclusion: Without such quantitative knowledge, limited insights can be gained about the causal
relationship between melatonin and the etiology of breast cancer from epidemiological studies and
from parametric studies using animal models.
Background
The incidence of breast cancer has grown continuously
since the turn of the twentieth century in industrialized
societies [1,2]. In 1978, Cohen and colleagues [3] put for-
ward the hypothesis that the pineal gland might play a
role in breast cancer etiology. In 1987, Richard Stevens [4]
put forward the "melatonin hypothesis" as a possible
explanation for at least part of the growing incidence of
breast cancer [4]. According to his hypothesis, the high
incidence of breast cancer in industrialized society was,
perhaps, caused by electricity in modern buildings
through reductions in melatonin concentrations, a hor-
mone produced at night and under conditions of dark-
ness. He postulated that one of the electricity-induced
reductions in melatonin was a result of electric light at
night (LAN). It is important to note that light is formally
defined in terms of a specific visual response in humans
[5]. It is technically incorrect to use the term light or light-
ing when referring to other species, or in relation to non-
visual (e.g., circadian) responses in humans. The term
optical radiation is most accurate to describe the portion
of the electromagnetic spectrum spanning ultraviolet, vis-
ible, and infrared radiation. However, the terms light and
lighting are widely used to describe optical radiation in
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the biological and medical research community, and
these terms are used interchangeably, albeit technically
incorrectly, throughout this paper.
The melatonin hypothesis stimulated various lines of
research, from laboratory studies using animal models to
epidemiological studies with humans. Suppression of
melatonin was hypothesized to increase production of
estrogens in the ovaries, which in turn would stimulate
the turnover of breast epithelial stem cells, thereby
increasing the likelihood of cancer [3]. Low melatonin
levels in rats were also shown to increase cancer cell pro-
liferation in existing tumors [6,7]. Epidemiological stud-
ies showed night-shift work, a surrogate for LAN,
increased the likelihood of breast and colorectal cancer [8-
11]. Thus, although no direct causal link has ever been
established between breast cancer and LAN in architec-
tural spaces, several researchers have suggested plausible
links between increased cancer risk and electric LAN
through melatonin depletion or disruption.
It is widely accepted that light exerts a powerful influence
on the human circadian system, including melatonin syn-
thesis, and it is becoming more widely accepted that the
circadian system plays a role in breast cancer [12]. For
example, the efficacy of breast cancer treatment varies
with circadian timing [13,14]. The present discussion
focuses on light as it affects melatonin, a potential media-
tor of cancer development and growth.
To establish causal links between architectural LAN, mela-
tonin levels and the growing incidence of breast cancer in
the general population, it is first and foremost necessary
to accurately specify the light stimulus (in terms of quan-
tity, spectrum, distribution, duration and timing [15]) as
it affects the human circadian system in industrialized
societies. Without this critical first step it is very difficult to
ascribe increased risk of breast cancer in women living in
industrialized societies to architectural lighting. The pur-
pose of this paper is to focus attention on the develop-
ment of a more quantitative characterization of circadian
light experienced by women and girls in modern societies
and, in particular, to begin to bridge that understanding to
epidemiological studies as well as to parametric labora-
tory studies using animal models.
The hormone melatonin is synthesized by the pineal
gland at night and under conditions of darkness in mam-
mals [16]. Synthesis and release of melatonin follow a
robust circadian rhythm and are highly governed by the
light-dark cycle. Reiter and colleagues [17] have shown
that melatonin participates in various physiological proc-
esses, including immune system functions. Melatonin can
prevent damage to DNA, and DNA that is not repaired can
mutate and initiate cancer [18,19]. Melatonin also partic-
ipates in the regulation of circadian rhythms of cell
metabolism and inhibition of chemically-induced car-
cinogenesis in rats as well as the growth of tumors in rats
[6,7,20].
Very recently, Blask and colleagues [20] showed that expo-
sure to different levels of white fluorescent light during
the 12-hour dark phase resulted in a dose-dependent sup-
pression of melatonin in rats bearing rat hepatomas or
human breast cancer xenografts. Further, they showed
that exposure to increasing levels of white light (from 0 to
345 μW/cm2) resulted in dose-dependent stimulation of
tumor growth and linoleic acid uptake and metabolism.
Relatively low light levels (0.1 μW/cm2) suppressed noc-
turnal melatonin in these rats. Blask and colleagues also
showed that human nocturnal melatonin signals inhibit
activities such as linoleic acid uptake that are associated
with human breast cancer growth and that this effect is
diminished by ocular exposure to bright, white light at
night. They exposed women to 2800 lux of white light
(580 μW/cm2) at eye level, which resulted in an approxi-
mately 40% reduction of melatonin levels in blood com-
pared to darkness levels. Perfusing tumors bearing human
breast cancer xenografts with this melatonin-depleted
human blood resulted in increased linoleic acid uptake in
the xenografts, which is related to increased cancer growth
[20]. Although this landmark study is limited to an indi-
rect relationship between melatonin and cancer growth
rates, melatonin depletion might also have important
implications for cancer development [21].
Also, consistent with Stevens's [4] melatonin hypothesis,
epidemiological studies suggest that night-shift work is
associated with an increase in breast and colorectal cancer
risk, potentially mediated through melatonin suppression
by exposure to LAN. Tynes and colleagues [8], Hansen [9]
and Davis and colleagues [10] studied women performing
night-shift work and all of the authors concluded that
female night-shift workers were at higher risk of breast
cancer compared to daytime workers. Two prospective
cohort studies utilizing data from the Nurses' Health
Study [22] showed a relative risk of 1.36 (95% CI, 1.04–
1.78) associated with 30 years or more of rotating night-
shift work and a relative risk of 1.79 (95% CI, 1.06–3.01)
associated with 20 years or more of rotating night-shift
work, after controlling for known breast-cancer risk fac-
tors [11].
Finally, epidemiological studies suggest that blind
women, who are less likely to suppress melatonin by LAN,
are at lower risk of breast cancer than sighted women [23].
Although these results also suggest that LAN may be
linked to an increased risk of breast cancer, Lockley and
colleagues [24] showed that the urinary metabolite of
melatonin (aMT6s) output (mg of aMT6s per 24 h) andJournal of Carcinogenesis 2006, 5:20 http://www.carcinogenesis.com/content/5/1/20
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amplitude (micrograms per h) of blind women with and
without light perception did not differ.
Recommendations for lighting practice are being made
based on extrapolations from these animal and epidemi-
ological studies [25]. However, without proper quantifi-
cation of LAN as it affects the human circadian system
outside laboratory conditions, particularly those using
animal models, generalizations from research linking
melatonin to cancer initiation and progression cannot be
meaningfully made and implications for architectural
lighting cannot be responsibly proposed. Again, this
paper attempts to lay the foundation for a more complete,
quantitative characterization of circadian light in the built
environment as a fundamental step toward understand-
ing the links between light, circadian regulation, mela-
tonin and breast cancer risk.
Light in Architectural Spaces
Although perhaps surprising to those outside the field of
architectural lighting, incandescent residential lighting
levels are typically lower than those experienced in offices
and much lower than those experienced outdoors during
the daytime. General ambient light levels on the floor or
other horizontal surfaces in a home rarely exceed 300 lux
[26]. Even for special visual tasks in residences, such as
grooming and cooking, vertical light levels likely to be
incident on the face or eyes are usually between 50 and
200 lux, and light levels on the visual task rarely exceed
500 lux. Light levels from fluorescent lamps on task areas
in commercial and industrial spaces can be two to three
times higher, and those outdoors from daylight and sun-
light can be 20 to 100 times greater. In buildings illumi-
nated by ceiling luminaries containing fluorescent lamps,
which direct light downward, light levels at the cornea are
about one-fifth of those measured on a horizontal surface,
so in the home, ambient illuminances from incandescent
lamps rarely exceed 200 lux at the cornea, and more typi-
cally at night are between 10 and 100 lux, based on meas-
urements of vertical illuminances in several residences
(Table 1[27]) and based on data obtained with a new
instrument designed to record and store (for up to a week
at a time) both conventional photopic illuminance and
circadian light exposure measurements made at the plane
of the eye [28].
Figures 1 and 2 show representative profiles of circadian
light exposure for two diurnal women working in a day-
lighted office during the day, and for two night-shift
nurses, respectively, along with expected outdoor light
exposures from daylight [26] at the same geographic loca-
tion as the women represented in the two figures.
As seen in Figure 1, the two diurnal women working
indoors were exposed to dim, extended and aperiodic cir-
cadian light exposure quite unlike a hypothetical woman
working outdoors under a robust light-dark cycle,
assumed to be ideal for regulating the circadian system.
Note too that the times of light exposure for both of these
day-shift women have been extended several hours
beyond sunset and that the magnitude and the variation
in these nocturnal light exposures are similar to those they
experienced during the day. Interestingly as well, light
exposure in public spaces from high intensity discharge or
fluorescent lamps, such as in gymnasia, for example, are
much higher than residential light exposures, and can be
experienced for several hours, so these events, if experi-
enced on a regular basis, could possibly be of greater
impact on circadian regulation and melatonin production
than the ambient lighting from incandescent lamps typi-
cally found in residences.
Figure 2 shows similar data to those in Figure 1 but for
two female nurses who work during the night shift. These
women also experience low light exposures relative to
outdoor daytime light levels, but this would be expected
because they are asleep during most of the daytime. These
night-shift women also seem to have relatively lower light
exposures during their waking hours than the day-shift
women experienced during their waking hours.
It should be emphasized that the lighting profiles in Fig-
ures 1 and 2 are only "snapshots" of light exposure expe-
rienced by day- and night-shift workers. Much longer
recording periods would likely be necessary to accurately
predict circadian response to light because the sensitivity
Table 1: Vertical (at the Cornea) Photopic Illuminance Measurements [27] in Several Interior and Exterior Locations
Location Median (lx) Minimum (lx) Maximum (lx)
windowed offices (78 locations in 12 rooms) 201 24 2050
windowless offices (68 locations in 12 rooms) 95 22 271
hospital patient rooms (53 locations in 5 rooms) 121 15 1182
hospital nurse stations (66 locations in 9 rooms) 126 22 837
hospital common areas (16 locations in 2 rooms) 319 26 1357
residential kitchens (48 locations in 5 rooms) 11 4 73
residential bedrooms (14 locations in 4 rooms) 43 8 170
parking lots (120 locations in 4 lots) 7 1 95Journal of Carcinogenesis 2006, 5:20 http://www.carcinogenesis.com/content/5/1/20
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Light profiles, in photopic illuminance (solid gray, left ordinate scale) and in circadian stimulus (solid black, right ordinate scale)  units [37], for two women working in daylighted offices in Troy, NY, USA Figure 1
Light profiles, in photopic illuminance (solid gray, left ordinate scale) and in circadian stimulus (solid black, right ordinate scale) 
units [37], for two women working in daylighted offices in Troy, NY, USA. Measurements were made continuously starting at 
15:00 on 1 December 2005 until 14:30 on 2 December 2005. Also shown are vertical photopic illuminances (dashed black, left 
ordinate scale) expected from outdoor exposure to a partly cloudy sky at the same location on the same date in open country 
for a 45° azimuth angle from the sun [26].Journal of Carcinogenesis 2006, 5:20 http://www.carcinogenesis.com/content/5/1/20
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Light profiles, in photopic illuminance (solid gray, left ordinate scale) and in circadian stimulus (solid black, right ordinate scale)  units [37], for two night shift nurses working in South Bend, IN, USA Figure 2
Light profiles, in photopic illuminance (solid gray, left ordinate scale) and in circadian stimulus (solid black, right ordinate scale) 
units [37], for two night shift nurses working in South Bend, IN, USA. Measurements were made continuously starting at 15:00 
on 30 January 2006 until approximately 15:00 on 31 January 2006. Also shown are vertical photopic illuminances (dashed black, 
left ordinate scale) expected from outdoor exposure to a partly cloudy sky at the same location on the same date in open 
country for a 45° azimuth angle from the sun [26].Journal of Carcinogenesis 2006, 5:20 http://www.carcinogenesis.com/content/5/1/20
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of the circadian system to LAN on a particular night will
be affected by a person's light exposure history. Sensitivity
to LAN in terms of melatonin suppression has been
shown to be higher (i.e., less light is needed to suppress
melatonin) after a prior history of exposure to low light
levels and lower after a prior history of high light levels
[29-31]. Thus, it probably will be necessary to track several
days of light and dark exposures to begin to understand
the impact of LAN on nocturnal melatonin suppression
for people in their natural environments.
Light in Animal Laboratories
To link architectural LAN to breast cancer risk, the lighting
profiles experienced by people, such as those in Figures 1
and 2, ultimately need to be translated into parametric
lighting studies with laboratory animals used as models
for cancer research. Bullough and colleagues [32], after a
literature review and calculations, showed that threshold
levels of light (quantity, spectrum, distribution and dura-
tion) for activation of the circadian systems of nocturnal
rodents commonly used as cancer models can be as much
as 10,000 times lower than the threshold levels needed to
activate the circadian systems of diurnal species such as
humans. As suggested above, this profound species differ-
ence is clearly demonstrated in the work of Blask and his
colleagues, where only 0.1 μW/cm2 of white light was suf-
ficient to reliably suppress nocturnal melatonin in rats
[20,33], but 580 μW/cm2 (2800 lux) was necessary to sup-
press nocturnal melatonin in women by 40% [20]. Not
only is this level several orders of magnitude greater than
the threshold for melatonin suppression in nocturnal
rodents, it is equivalent to daytime light levels found out-
doors during the morning and not at all similar to light
levels produced by architectural LAN, especially in resi-
dences (Table 1). Further, experimental data suggest that
nocturnal rodents such as mice [34] do not reliably
exhibit spectral opponency in circadian phototransduc-
tion, although humans and diurnal primates do appear to
exhibit opponency [35-38]. These comparisons among
species underscore the importance of properly character-
izing light as a stimulus to the circadian systems in both
humans and in the nocturnal rodents used as animal
models for understanding human breast cancer etiology.
Light levels in animal laboratories designed in the 1990s
have typically been specified to be about 600 to 800 lux of
white light on a horizontal plane one meter above the
floor [39], corresponding to an irradiance of about 150
μW/cm2. More recently, recommendations [40] have been
reduced to about 300 to 325 lux (about 70 μW/cm2) to
help reduce the incidence of retinal damage in nocturnal
rodents by lighting. Regardless, these light levels would
still be likely to result in illuminances at the eyes of
rodents housed in such laboratories well above the 0.1
μW/cm2  threshold for melatonin suppression [20,33].
Such disparities between typical human light exposures
and the conditions used in the study of cancer in noctur-
nal rodents will need to be much better addressed before
a quantitative understanding of architectural LAN and
breast cancer risk can be developed from laboratory stud-
ies where animal models are used.
LAN as a Stimulus for Melatonin Suppression
Once quantitative estimates of the light levels experienced
by women at night have been determined, either for inter-
preting epidemiological studies or for designing paramet-
ric laboratory studies using animal models, the functional
relationships between complex light exposures and mela-
tonin suppression in humans must then be established.
These relationships can then be meaningfully used to
begin to assess the importance of LAN for suppressing
nocturnal melatonin in actual architectural spaces. A
model of human circadian phototransduction relating
light exposure in laboratory environments to nocturnal
melatonin suppression was developed by Rea and col-
leages [37]. Figure 3 is based upon that model and shows
nocturnal melatonin suppression in humans as a function
of the modeled circadian light stimulus. The solid line is
the best fitting functional relationship between the mod-
eled circadian light stimulus and nocturnal melatonin
suppression values for humans from a number of empiri-
cal studies using both monochromatic and polychromatic
light [35,41-45]. The circadian light stimulus values on
the abscissa in Figure 3 are for a 60 minute light exposure,
but, obviously, durations shorter or longer than 60 min-
utes will have less or more effect on melatonin suppres-
sion for the same circadian light level and spectrum [41].
In fact, the solid line in Figure 3 is based on data from 30
[43], 60 [35,41,44,45], and 90 minutes [42]; the data were
adjusted empirically to account for those different dura-
tions. Also shown in this figure are the resulting circadian
light stimulus values for varying illuminances of two con-
ventional light sources, incandescent and daylight illumi-
nants [46].
Figure 4 shows the individual curves of the same form as
in Figure 3, fitted to the 30-, 60- and 90-minute data sep-
arately. Table 2 shows the predicted values of nocturnal
melatonin suppression for incandescent and daylight illu-
mination, at different light levels and for different expo-
sure durations; the values are based upon the three
functions in Figure 4.
It should be noted that the 90-minute suppression values
for the daylight source are consistent with those recently
published by Zeitzer and colleagues [47], who found a
half-maximal value of melatonin suppression in subjects
exposed to three consecutive (over three days) 5-hour
pulses of light at an illuminance (at the eyes) of around
100 lux. The uncertainty in the predicted values in Table 2Journal of Carcinogenesis 2006, 5:20 http://www.carcinogenesis.com/content/5/1/20
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is, however, reflected in Figure 3. Empirically, for a spe-
cific circadian light stimulus value, the range in mean noc-
turnal melatonin suppression would be expected to be
approximately 20%, or ± 10% of the predicted value. This
level of uncertainty is also consistent with the confidence
intervals for predicted melatonin suppression identified
by Zeitzer and colleagues [47].
The studies of human nocturnal melatonin suppression to
light in the laboratory illustrated in Figure 3 show that a
reliable threshold for measurable melatonin suppression
(approximately 15%, given the approximately ± 10%
uncertainty in prediction of melatonin suppression) is,
depending upon the spectral power distribution [37],
about 30 lux of white light at the cornea for a 60-minute
exposure [41,44,45]. Based then on the values in Table 2,
it can be inferred that melatonin levels should be largely
unaffected by brief (i.e., less than 30 minutes) exposures
to the relatively low ambient levels of white (incandes-
cent) light typically found in residences (i.e., less than 30
lux). Threshold values will undoubtedly be different for
different individuals with different light histories [29-31]
and with different demographic characteristics [48,49],
but 30 lux for 30 minutes is proposed here as a working
expected threshold value for women living in North Ameri-
can residences until more specific data are available. It is
important to note again, however, that when additional
task lights are used in the home for critical visual tasks,
such as reading, sewing or grooming, light levels at the
cornea can reach 150 to 200 lux at the eye [26]. Working
under these light levels for several hours in the evening
should in fact impact the onset of nocturnal melatonin
production, but not necessarily in a clear or unambiguous
way. Two studies have shown that LAN experienced by
diurnally active adults in their homes has no impact on
total nocturnal melatonin production, and only a small
effect on phase [50,51]. On the other hand, in long sleep-
ers (sleep duration longer than 9 hours) the duration of
nocturnal melatonin production was greater than that in
short sleepers (sleep duration less than 6 hours) under a
constant routine protocol and exposure to less than 10 lux
at the eye, although the amplitude of melatonin produc-
tion was not significantly different [52]. Wehr [53]
showed that the duration of nocturnal melatonin produc-
tion was longer when subjects were exposed to a short
photoperiod compared to a long photoperiod. Unfortu-
nately, however, the quantity and spectrum of the light
exposure was undefined, both indoors and outdoors. In
sum, although it seems like long or short sleepers will dif-
fer in their nocturnal melatonin production duration, no
studies have investigated whether this is due to individual
differences (i.e., one is a long sleeper because he/she nat-
urally produces melatonin for a longer duration over the
course of the night) or if LAN typically found in real-life
applications affects melatonin production duration in
either long or short duration sleepers.
It is also important to stress that although a working
threshold dose of light for nocturnal melatonin suppres-
sion in the home (i.e. 30 lux of white light for 30 minutes)
could possibly be a useful starting point for discussion of
a "safe" amount of light at night, it is clearly beyond our
Predicted melatonin suppression as a function of circadian  light stimulus (CS) [37] for different exposure durations,  based on fitting the logistic-form curve in Figure 3 to the data  separately for 30 minute [43], 60 minute [35,41-45] or 90  minute [42] exposure durations Figure 4
Predicted melatonin suppression as a function of circadian 
light stimulus (CS) [37] for different exposure durations, 
based on fitting the logistic-form curve in Figure 3 to the data 
separately for 30 minute [43], 60 minute [35, 41-45] or 90 
minute [42] exposure durations.
Melatonin suppression [35, 41-45] as a function of circadian  stimulus (CS) [37] Figure 3
Melatonin suppression [35, 41-45] as a function of circadian 
stimulus (CS) [37]. Horizontal arrows show the correspond-
ing CS value for varying corneal illuminances from incandes-
cent (solid arrows) and daylight (dashed arrows) illumination 
[46]for one hour exposures. The shaded band represents the 
modeled best fit (solid black line, r2 = 0.82) using a four-
parameter logistic equation [47] and the standard errors of 
the best-fitting coefficients to the model.Journal of Carcinogenesis 2006, 5:20 http://www.carcinogenesis.com/content/5/1/20
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collective current understanding to suggest that this value,
or any other, is a "safe" dose of light. It is equally prema-
ture to suggest that LAN is "unsafe," particularly without a
proper, species-specific quantitative framework for such
statements. What will be meaningful in the context of
women's health is to base such discussions on existing
data, or to generate new data, and to begin to move from
a qualitative to a quantitative discussion of circadian LAN.
In the context of safety and health, it is also important to
reconsider one purpose of LAN, namely to provide people
with a "safe" nocturnal environment via properly speci-
fied emergency lighting [54,55] or security lighting
[56,57]. Arguably it is safer to use light of modest intensity
and duration to reduce risks of trips and falls during noc-
turnal visits to the bathroom and kitchen than to leave the
lights off or to use lighting that is insufficient for visual
navigation at home. In this context, however, safe naviga-
tion throughout the house does not require high light lev-
els [55]. For example, vanity lights around a mirror
operated by a switch located at the bathroom door usually
provide much higher light levels at the eye than are neces-
sary for safe navigation [26]. For safe movement through
the house in the middle of the night it is usually only nec-
essary to employ a secondary, low-level lighting system
that does not exceed 30 lux of white light at the cornea for
more than a few minutes. Some have suggested that only
"red" dim night-lights be used, but this recommendation
seems unnecessarily restrictive, especially because the vis-
ual system is not particularly sensitive to long-wavelength
radiation and, therefore, safe navigation could be seri-
ously hindered. In fact, utilizing light levels high enough
for safe navigation but low enough to minimize circadian
stimulation for short exposure times (less than 30 min-
utes) is especially important for senior adults who can
have difficulty seeing and walking [58]. Falls among older
adults have been associated with increased mortality [59].
To avoid risk of trips and falls due to temporary loss of
sensitivity during dark adaptation after lights are shut off,
a secondary, low-level lighting system for nighttime appli-
cations could, again, be quite important to health and
well-being of senior adults [60].
It is also worth mentioning concerns expressed about the
possible impact of light from the street or from adjacent
properties entering the bedroom at night after lights in a
residence have been turned off. These light levels rarely
exceed 10 lux at the cornea outdoors (Table 1). Indoors,
behind closed curtains, the levels would be likely to be
much lower. Further, the human eyelids transmit only
Table 2: Predicted Human Nocturnal Melatonin Suppression from Incandescent and Daylight Illumination [46] of Varying Corneal 
Illuminances and Durations, Based on Rea et al. [37]
Incandescent
Illuminance (lx) Melatonin suppression after 30 minutes Melatonin suppression after 60 minutes Melatonin suppression after 90 minutes
0.1 0% 0% 0%
0.3 0% 0% 0%
10 % 1 % 1 %
31 % 2 % 2 %
10 3% 5% 5%
30 8% 11% 13%
100 19% 25% 27%
300 35% 42% 45%
1000 54% 59% 60%
3000 65% 68% 69%
Daylight
Illuminance (lx) Melatonin suppression after 30 minutes Melatonin suppression after 60 minutes Melatonin suppression after 90 minutes
0.1 0% 0% 0%
0.3 0% 0% 1%
11 % 1 % 1 %
32 % 3 % 4 %
10 6% 9% 10%
30 14% 19% 20%
100 29% 36% 39%
300 47% 53% 55%
1000 62% 65% 66%
3000 69% 71% 71%Journal of Carcinogenesis 2006, 5:20 http://www.carcinogenesis.com/content/5/1/20
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about 1% to 3% in the short wavelength region of the vis-
ible spectrum [61], so 1000 to 3000 lux at the closed eye-
lid would be needed for one hour to reach the threshold
for melatonin suppression in humans. In fact, Jean-Louis
and colleagues [62] showed that a one-hour exposure of
1700 lux of white light at the eyelids (delivered via a light
mask) did not suppress nocturnal melatonin in humans.
Hatonen and colleagues [63] showed that, on average,
2000 lux of white light applied to closed eyelids for 1 hour
did not significantly suppress melatonin, although a quar-
ter of their subjects did show some suppression. In this
regard, individual differences may become a more impor-
tant consideration in the future. Nevertheless, their con-
clusion was that indoor light was likely ineffective to the
circadian system while one is asleep because light levels
typically found in indoor environments are much lower
than 2000 lux at the eye. Arguments for using black-out
shades to limit light in the home at night because of its
possible link to cancer risk have no quantitative founda-
tion for melatonin suppression within the context of peo-
ple living normal lives and working day-shifts. Of course,
light trespass in our bedrooms should be avoided, but for
the right reasons: light trespass is annoying and wasteful.
Given the available published data on human melatonin
suppression in response to light, light trespass through
residential windows is an unlikely cause of melatonin
suppression, simply because the light levels are so low,
particularly with the eyes closed.
Night-Shift Work as a Surrogate for LAN
Obviously, light is required to perform night-shift work.
Because LAN can suppress nocturnal melatonin and
because no instruments have previously been available to
conveniently and accurately measure circadian light expo-
sure, epidemiological studies have used night-shift work
as one surrogate for LAN. In fact, studies on the relation-
ship between LAN actually experienced by night-shift
women and melatonin depletion have not been consist-
ent with the assumption that LAN always suppresses
melatonin [64,65]. Nevertheless, there should be a real
societal concern about women performing night-shift
work. As previously noted, a growing number of epidemi-
ological studies show that night-shift work places women
at a higher risk for breast cancer [9-11].
Measurements in several office and hospital workplaces
(Table 1[27]) clearly show that vertical illuminances from
white light likely to be experienced in the workplace for
durations longer than 30 minutes can regularly exceed 30
lux. Measurements of light levels in neonatal intensive
care units [66], for example, operated both day and night
also showed that light levels could be high enough to
result in nocturnal melatonin suppression (Table 2). It is
reasonable to suppose then that night-shift women expe-
rience light levels bright enough and long enough to sup-
press nocturnal melatonin while they work at night. The
data in Figure 2 suggest, if these women are typical, that
the light levels to which they are exposed during the day
are lower than those experienced at night, so that night-
shift nurses do experience a regular, albeit muted and per-
haps irregular, light-dark cycle. What is not yet clear, of
course, is the circadian phase of these women with respect
to their light-dark cycle. Data from Burgess and Eastman
[50,51] suggest that the total melatonin levels across the
24-hour day might be unaffected by shortened sleeping
schedules even though the phase of melatonin produc-
tion is altered by both evening and morning light and by
the sleep-wake cycle. In the context of night-shift work, lit-
tle is known about the impact of long-term adaptation to
different light-dark cycles over time [29,30]. LAN should
not then be considered out of context of the light-dark
cycle actually experienced by night-shift women and with-
out a much better understanding of workers' adaptation
to their working and sleeping schedule.
Night-shift women may also be at a higher risk of tumor
growth for reasons apart from those associated with LAN.
There are potential dietary differences between day- and
night-shift workers [67] and this could be especially
important if night-shift workers are consuming higher lev-
els of linoleic acid [7]. Caffeine (100 mg) given four times
a night was shown to reduce onset of melatonin levels in
women in their luteal phase in the same manner as bright
light [68]. Studies have also shown that sleep deprivation
negatively impacts the immune system [69,70] and night-
shift workers are generally sleep deprived because the
quality of daytime sleep is often worse than nighttime
sleep. It is important to add, however, that a recent epide-
miological study failed to statistically show that occupa-
tional factors, such as sleep rhythms disruptions, were
positively related to breast cancer risk among Finnish
flight attendants [71]. Schernhammer and colleagues [72]
also examined the relationship between melatonin and
lifestyle factors and other endogenous sex steroid hor-
mones. They concluded that age, body mass index, and
heavy smoking were significantly related to lower levels of
melatonin, while parity was significantly related to higher
levels of melatonin. No other reproductive factors or sex
steroid hormones were significantly associated with mela-
tonin levels. Of course, more studies are needed to con-
firm their results. Moreover, although melatonin has been
shown to have oncostatic effects (for review, see [73]), it
may not be the only hormone important to breast cancer
risk [74,75]. Clearly then, the higher risk of breast cancer
associated with night-shift work is not related to LAN in a
simple, easily defined way. Indeed, LAN associated with
night-shift work may be entirely beneficial to night shift
workers in helping entrain their circadian rhythms to the
nighttime hours, and very different than LAN associated
with diurnal lifestyles.Journal of Carcinogenesis 2006, 5:20 http://www.carcinogenesis.com/content/5/1/20
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Conclusion
Stevens [4] suspected that LAN in the built environment
might be associated with increased incidence of breast
cancer in industrialized societies. The present quantitative
review and assessment of the circadian light stimulus
experienced by diurnal women in their homes indicates
that LAN, at least for those women, does not always
approach the expected threshold for reliable melatonin
suppression (Tables 1 and 2). Three points are important
to consider, however. First, it is probably common for
some diurnal women to experience light levels and dura-
tions above the expected threshold for nocturnal mela-
tonin suppression, even in the home. However, the
conditions and significance under which LAN above
threshold might affect the duration and phase of mela-
tonin production as well as the overall level of nocturnal
melatonin production [50-53] are not well understood,
especially in natural environments. Second, individual
circadian light exposures over much longer periods than
just 24 hours need to be considered in assessing a person's
own sensitivity to light, its impact on melatonin suppres-
sion and, of course, risk of breast cancer. Third, our collec-
tive, current body of knowledge is entirely inadequate
with regard to establishing "safe" or "unsafe" light levels
and durations as they affect nocturnal melatonin suppres-
sion. Indeed, it is not known to what extent, if at all, circa-
dian light exposure at night might impact breast cancer
etiology in diurnal women.
The epidemiological evidence strongly suggests, however,
that breast cancer is associated with night-shift work, but
not necessarily with LAN exclusively [76]. Light during the
solar night does regularly exceed the expected threshold
for melatonin suppression in night-shift women, as
would be expected, since they must perform their work at
this time. During the solar day, when night-shift women
would be expected to be sleeping, illuminance levels are
generally lower than they are at night, but could possibly
be influenced by daylight (e.g., Figure 2, top panel). In
these night-shift women, lifestyle choices, including those
during non-working days, almost certainly affect circadian
phase and melatonin availability in ways uncharacteristic
of diurnal women.
The link between melatonin suppression and cancer
growth in laboratory animals nevertheless appears to be
real and is undoubtedly important [20]. However, no
studies have established a clear link between circadian
light exposures commonly experienced by women at
night and cancer etiology in rodents. Fundamentally, it
will be impossible to understand the role of architectural
LAN in breast cancer etiology until extended light expo-
sure profiles experienced by women and girls in modern
societies are properly characterized and then formally
transformed into light exposure profiles for controlled
studies of breast cancer using animal models. This has yet
to be accomplished, but Bullough and colleagues [32] and
Bierman and colleagues [28] have made significant steps
toward making this bridge. Coupled with the pioneering
studies of circadian regulation and breast cancer that have
already been made [13,14,20,33] it may finally be possi-
ble to begin to determine what role architectural lighting
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